RANZCP homepage
Alexander Lim
Presenters
Dr Alexander Lim
Dr Alexander YC Lim is a consultant psychiatrist, and the Founder and Director of Zed3 Medical Group, headquartered in Canberra.
Specialising in the clinical care of current and former serving uniformed personnel including Defence, veterans, and first responders; he set up Australia’s first ketamine clinic for veterans which has now expanded to three sites.Dr Lim maintains high-level advocacy with government and non-government organisations, and is a member of both the RANZCP committee for Military, Veterans, Emergency Services Personnel Network (MVESPHN) and the Section for Private Practice Psychiatrists (SPPP).
Dr Lim is also actively engaged in research, partnering with domestic and international research organisations, and holding membership with the International Society for Traumatic Stress Studies (ISTSS) and the European Society for Traumatic Stress Studies (ESTSS). He formerly worked as a ministerial adviser to a cabinet minister in the Howard Government.
Dr Lim’s main interests lie in:
Specialising in the clinical care of current and former serving uniformed personnel including Defence, veterans, and first responders; he set up Australia’s first ketamine clinic for veterans which has now expanded to three sites.Dr Lim maintains high-level advocacy with government and non-government organisations, and is a member of both the RANZCP committee for Military, Veterans, Emergency Services Personnel Network (MVESPHN) and the Section for Private Practice Psychiatrists (SPPP).
Dr Lim is also actively engaged in research, partnering with domestic and international research organisations, and holding membership with the International Society for Traumatic Stress Studies (ISTSS) and the European Society for Traumatic Stress Studies (ESTSS). He formerly worked as a ministerial adviser to a cabinet minister in the Howard Government.
Dr Lim’s main interests lie in:
- Clinical paradigms for priority groups with a high prevalence of co-morbidity;
- Translation between research and policy to address needs in these priority groups; and
- Advocacy to enable change in organisational silos.
Dr Alexander YC Lim is a consultant psychiatrist, and the Founder and Director of Zed3 Medical Group, headquartered in Canberra.
Specialising in the clinical care of current and former serving uniformed personnel including Defence, veterans, and first responders; he set up Australia’s first ketamine clinic for veterans which has now expanded to three sites.Dr Lim maintains high-level advocacy with government and non-government organisations, and is a member of both the RANZCP committee for Military, Veterans, Emergency Services Personnel Network (MVESPHN) and the Section for Private Practice Psychiatrists (SPPP).
Dr Lim is also actively engaged in research, partnering with domestic and international research organisations, and holding membership with the International Society for Traumatic Stress Studies (ISTSS) and the European Society for Traumatic Stress Studies (ESTSS). He formerly worked as a ministerial adviser to a cabinet minister in the Howard Government.
Dr Lim’s main interests lie in:
Specialising in the clinical care of current and former serving uniformed personnel including Defence, veterans, and first responders; he set up Australia’s first ketamine clinic for veterans which has now expanded to three sites.Dr Lim maintains high-level advocacy with government and non-government organisations, and is a member of both the RANZCP committee for Military, Veterans, Emergency Services Personnel Network (MVESPHN) and the Section for Private Practice Psychiatrists (SPPP).
Dr Lim is also actively engaged in research, partnering with domestic and international research organisations, and holding membership with the International Society for Traumatic Stress Studies (ISTSS) and the European Society for Traumatic Stress Studies (ESTSS). He formerly worked as a ministerial adviser to a cabinet minister in the Howard Government.
Dr Lim’s main interests lie in:
- Clinical paradigms for priority groups with a high prevalence of co-morbidity;
- Translation between research and policy to address needs in these priority groups; and
- Advocacy to enable change in organisational silos.
